199 related articles for article (PubMed ID: 22173677)
21. Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.
Osumi M; Tashiro T; Morita Y; Kamiya S; Minematsu N; Nishimi M; Wada H
Adv Ther; 2014 Oct; 31(10):1109-17. PubMed ID: 25319249
[TBL] [Abstract][Full Text] [Related]
22. [Effects of landiolol on hemodynamic improvement and prevention of atrial fibrillation in the perioperative period of off-pump coronary artery bypass grafting].
Tanaka K
Kyobu Geka; 2010 Mar; 63(3):175-9; discussion 179-83. PubMed ID: 20214343
[TBL] [Abstract][Full Text] [Related]
23. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of an ultrashort-acting β1-blocker on left ventricular dysfunction.
Ito N; Tashiro T; Morishige N; Nishimi M; Hayashida Y; Minematsu N; Kuwahara G; Sukehiro Y; Teratani H
Heart Surg Forum; 2012 Aug; 15(4):E189-94. PubMed ID: 22917822
[TBL] [Abstract][Full Text] [Related]
25. Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
Niwa Y; Koike M; Iwata N; Kobayashi D; Tanaka C; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Hepatogastroenterology; 2014 Sep; 61(134):1546-51. PubMed ID: 25436340
[TBL] [Abstract][Full Text] [Related]
26. Cost-Effectiveness Analysis of Landiolol, an Ultrashort-Acting Beta-Blocker, for Prevention of Postoperative Atrial Fibrillation for the Germany Health Care System.
Walter E; Heringlake M
J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):888-897. PubMed ID: 31837963
[TBL] [Abstract][Full Text] [Related]
27. Effects of Landiolol on Macrocirculatory Parameters and Left and Right Ventricular Performances Following Cardiac Surgery: A Randomized Controlled Trial.
Ferraris A; Jacquet-Lagrèze M; Cazenave L; Fornier W; Jalalzai W; Rousseau-Saine N; Pozzi M; Fellahi JL
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2864-2869. PubMed ID: 35337743
[TBL] [Abstract][Full Text] [Related]
28. Use of low-dose β
Sakai M; Jujo S; Kobayashi J; Ohnishi Y; Kamei M
J Cardiothorac Surg; 2019 Jul; 14(1):145. PubMed ID: 31345252
[TBL] [Abstract][Full Text] [Related]
29. A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Nakasu Y; Mizutani H; Sumitani K
J Cardiol; 2019 Nov; 74(5):418-425. PubMed ID: 31255463
[TBL] [Abstract][Full Text] [Related]
30. Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol.
Nakanishi K; Takeda S; Kim C; Kohda S; Sakamoto A
J Cardiothorac Surg; 2013 Jan; 8():19. PubMed ID: 23347432
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?].
Uehara K; Ueyama K; Ito H; Fukuda T; Sasaki K; Abe T; Nakane E; Miyamoto S; Haruna T; Inoko M; Nohara R
Kyobu Geka; 2010 Mar; 63(3):188-91. PubMed ID: 20214345
[TBL] [Abstract][Full Text] [Related]
32. Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
Taenaka N; Kikawa S
Clin Drug Investig; 2013 Jul; 33(7):505-14. PubMed ID: 23728899
[TBL] [Abstract][Full Text] [Related]
33. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
[TBL] [Abstract][Full Text] [Related]
34. Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Saitoh T; Matsushita M
J Cardiol; 2015 Jul; 66(1):69-72. PubMed ID: 25454208
[TBL] [Abstract][Full Text] [Related]
35. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
[TBL] [Abstract][Full Text] [Related]
37. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
Shibata SC; Uchiyama A; Ohta N; Fujino Y
J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):418-22. PubMed ID: 26703973
[TBL] [Abstract][Full Text] [Related]
39. Conversion of atrial fibrillation to sinus rhythm during landiolol infusion.
Mayahara T; Goto M; Sato M; Kanazawa T; Isomine S; Nakajima H; Sakaida K
J Anesth; 2004; 18(4):304-6. PubMed ID: 15549475
[TBL] [Abstract][Full Text] [Related]
40. Continuous administration of landiolol reduced QT dispersion in postoperative patients.
Suzuki K; Numaguchi A; Adachi YU; Obata Y; Hatano T; Ejima T; Sato S; Matsuda N
J Clin Anesth; 2014 Sep; 26(6):438-42. PubMed ID: 25204509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
